Vitamin C (ascorbate) is maintained at high levels in most immune cells and can affect many aspects of the immune response. Intracellular levels generally respond to variations in plasma ascorbate availability, and a combination of inadequate intake and increased turnover during severe stress can result in low plasma ascorbate status. Intracellular ascorbate supports essential functions and, in particular, acts as an enzyme cofactor for Fe- or Cu-containing oxygenases. Newly discovered enzymes in this family regulate cell metabolism and epigenetics, and dysregulation of their activity can affect cell phenotype, growth and survival pathways, and stem cell phenotype. This brief overview details some of the recent advances in our understanding of how ascorbate availability can affect the hydroxylases controlling the hypoxic response and the DNA and histone demethylases. These processes play important roles in the regulation of the immune system, altering cell survival pathways, metabolism and functions.

Background

Humans have an absolute requirement for vitamin C (ascorbate) as part of their diet, and deficiency due to inadequate intake is associated with a plethora of symptoms, reflecting the diverse functions attributed to the vitamin [14]. There is widespread belief that ascorbate supports the immune system, and claims along this line are frequently encountered, including on commercially available dietary supplements. Since its discovery more than 80 years ago, the function of ascorbate in the immune system has been the subject of much research and more than a little controversy. One of the main drivers of this interest is that leukocytes accumulate the vitamin to high intracellular concentrations, signalling an important role for it in these cells [59].

Additionally, in the last 15 years, the many cofactor functions of ascorbate have come to the fore. It is well established that ascorbate is a specific cofactor for many biosynthetic enzymes including dopamine β-hydroxylase, which converts dopamine to norepinephrine, and the collagen prolyl and lysyl hydroxylases which form cross-links to stabilise the tertiary structure of collagen [1013]. More recently, however, it has become apparent that ascorbate is also a cofactor for newly characterised hydroxylases that regulate gene transcription and cell signalling pathways [14,15]. These hydroxylases belong to the family of Fe-containing 2-oxoglutarate-dependent dioxygenases; members of this family are widespread throughout biology, and include enzymes involved in biosynthesis, post-translational protein modification and the oxidative demethylation of methylcytosine and methylated histone residues [1620]. Examples of these enzymes include N-trimethyllysine hydroxylase and γ-butyrobetaine dioxygenase that synthesise carnitine [16], and the prolyl, lysyl and arginine hydroxylases that modify collagen and the alpha regulatory subunit of the hypoxia-inducible factors [19,20].

This short review will focus on the cell signalling and gene regulatory (cofactor) actions of vitamin C and their potential roles in regulating the immune system. The contributions of ascorbate as an antioxidant in immune cells have been well reviewed by others [2127] and will not be discussed here. We will consider the functional effects of ascorbate on cells of both the innate and adaptive immune responses that particularly reflect the cofactor activity of ascorbate and include a discussion of the role of vitamin C on immune cells in cancer.

Ascorbate levels in immune cells

The optimal concentration of ascorbate required for its cofactor activity supporting the Fe- and Cu-containing enzymes in vitro is in the mM range [28], similar to the intracellular levels measured in many cell types [1,29,30]. The ascorbate content of immune cells is also in this range and reflects plasma availability. Intracellular ascorbate concentrations in circulating lymphocytes, monocytes and neutrophils have been reported to be ∼3.5, ∼3 and ∼1.5 mM, respectively, when plasma levels are at least 50 µM, reflecting the status in healthy individuals consuming ≥100 mg ascorbate daily [8,31]. However, when plasma levels fall below 50 µM, immune cell ascorbate content decreases, with intracellular concentrations at ∼1.5, 1.2 and 0.5 mM in lymphocytes, monocytes and neutrophils, respectively, when plasma levels are ≤20 µM [8,31]. Plasma levels below 23 µM represent a state of hypovitaminosis C and are commonly seen in individuals with low fresh fruit and vegetable intake [3236]. In addition, there is substantial evidence that plasma and cellular ascorbate levels are depressed in conditions of active inflammation [3740] and in cancer patients [4143], including patients with haematological cancers [4450]. Severely depleted plasma levels of ≤20 µM are commonly reported, particularly in very ill patient populations [37,40,44]. Ascorbate loss during illness is thought to reflect increased turnover due to oxidative and metabolic stress [51,52]. This variable availability of ascorbate may modulate ascorbate-dependent enzyme reactions and thereby affect immune cell function.

The cellular ascorbate content referred to above applies to mature circulating white blood cells. A recent report indicated that haematopoietic and multipotent stem cells and haematopoietic progenitor cells in the bone marrow contain 2- to 20-fold more ascorbate than differentiated cells and that increased ascorbate content correlated with increased expression of the specific ascorbate transporter, SVCT2 [53]. This information suggests an essential role for ascorbate in bone marrow stem cell differentiation. Evidence for this is accumulating, with recent reports of ascorbate-mediated regulation of epigenetic programming and differentiation in bone marrow stem cells and particularly in myeloid leukaemia cells containing mutations in TET2 or IDH1 [54,55]. For more in-depth information, the reader is referred to recent reviews of this interesting and fast-developing field of research [56,57].

The role of ascorbate in the hypoxic response and implications for immune cell function

The hydroxylase enzymes that regulate the activity of the hypoxia-inducible factors (HIF)s require ascorbate for optimal activity [28,29]. The HIFs are controlled by hydroxylation of proline and asparagine residues on the regulatory alpha subunit and, in response to changes in oxygen availability, they direct the transcription of hundreds of genes via the hypoxia response element [5861]. The dependence of the hydroxylases on ascorbate as a cofactor has been demonstrated in cell-free systems [28,61,62], with other reducing agents such as glutathione being very much less effective as a recycler of the hydroxylase active site Fe2+ [28,6365]. Depleted intracellular ascorbate levels have been shown to contribute to the up-regulation of HIF activation, particularly under conditions of mild or moderate hypoxia [29,66].

The interaction between ascorbate and the HIFs is relevant to the function of immune cells in both inflammation and cancer. Inflammatory sites are known to be under hypoxic stress, potentially as a consequence of the increased oxidative metabolism of inflammatory cells [6769]. Growing tumours are also well characterised as being hypoxic tissues due to rapid proliferation and outgrowth of the established blood supply [70,71]. The resulting up-regulation of the HIFs is instrumental in the activation of glycolysis, angiogenesis, resistance to chemotherapy and the promotion of a stem cell phenotype, thereby promoting tumour growth and metastasis [59,72,73]. At inflammatory sites and in tumour tissue, the hypoxic environment affects immune cell function and, given the interdependence between the activation of the HIFs and cellular ascorbate [14,29,7478], we propose that many effects of ascorbate on immune cell function are likely to reflect the regulation of HIF-mediated functions. Figure 1 shows a summary of the interactions that are discussed in the sections below.

A summary of the recently reported effects of ascorbate-dependent processes in immune cells.

Figure 1.
A summary of the recently reported effects of ascorbate-dependent processes in immune cells.

(A) Effects on myeloid cells and (B) lymphoid cells. Effects shown in black font represent a reported role of HIF, TET or Jumonji demethylases, text in red indicates a reported effect of HIF, TET or Jumonji in the context of cancer and orange text indicates an effect of ascorbate on immune cells. The inter-relationships between these are indicated by arrows. References from the Figure: Achuthan 2016 [135]; Agathocleous 2017 [53]; Anderson 1980 [164]; Backer 2017 [88] Berger 2013 [101]; Beyaz 2017 [162]; Bhandari 2013 [165]; Bozonet 2015 [108]; Braverman 2016 [86]; Campbell 1999 [166]; Cimmino 2017 [142]; Colegio 2014 [90]; Cramer 2003 [84]; Cribbs 2018 [163]; Cull 2017 [131]; Dang 2011 [112]; De Santa 2009 [137]; Doedens 2010 [93]; [113]; Fluck 2016 [115]; Gaut 2006 [107]; Goldschmidt 1991 [106]; Hammami 2018 [116]; He 2016 [167]; Henke 2016 [94]; Higashiyama 2012 [114]; Huijskens 2014,2015 [122,123]; Ichiyama 2015 [148]; Imtiyaz 2010 [87]; Ishii 2009 [139]; Jeong 2011,2014 [95,96]; Johnston 1991 [168]; Kasahara 2017 [158]; Kim 2012 [169]; Ko 2015 [170]; Kruidenier 2012 [141]; LaMere 2017 [151]; Labiano 2017 [119]; Li 2014 [153]; Li 2018 [83]; Lio 2016 [171]; Liu 2015 [154]; Maeng 2008 [172]; Manning 2013 [124]; Mecklenburgh 2002 [98]; Mingay 2018 [55]; Nair 2016 [156]; Nestor 2016 [147]; Nikolouli 2017 [157]; Noh 2005 [173]; Noman 2014 [92]; Northrup 2017 [161]; Oda 2006 [82]; Orlanski 2016 [174]; Palazon 2017 [117]; Perez-Cruz 2003 [103]; Peyssonnaux 2005 [85]; Ptaschinksi 2015 [146]; Puskas 2002 [175]; Satoh 2010 [134]; Shalova 2015 [89]; Shi 2011 [111]; Shilotri 1977 [176]; Song 2017 [159]; Talks 2000 [177]; Tsagaratou 2017 [160]; Vissers 2004,2007 [178,179]; Vojdani 1993 [180]; Wallner 2016 [132]; Walmsley 2005,2006 [99,100]; Wei 2009 [152]; Yan 2014 [140]; Yildirim 2017 [136]; Yue 2016 [155]; Zhang 2014,2015 [133,145].

Figure 1.
A summary of the recently reported effects of ascorbate-dependent processes in immune cells.

(A) Effects on myeloid cells and (B) lymphoid cells. Effects shown in black font represent a reported role of HIF, TET or Jumonji demethylases, text in red indicates a reported effect of HIF, TET or Jumonji in the context of cancer and orange text indicates an effect of ascorbate on immune cells. The inter-relationships between these are indicated by arrows. References from the Figure: Achuthan 2016 [135]; Agathocleous 2017 [53]; Anderson 1980 [164]; Backer 2017 [88] Berger 2013 [101]; Beyaz 2017 [162]; Bhandari 2013 [165]; Bozonet 2015 [108]; Braverman 2016 [86]; Campbell 1999 [166]; Cimmino 2017 [142]; Colegio 2014 [90]; Cramer 2003 [84]; Cribbs 2018 [163]; Cull 2017 [131]; Dang 2011 [112]; De Santa 2009 [137]; Doedens 2010 [93]; [113]; Fluck 2016 [115]; Gaut 2006 [107]; Goldschmidt 1991 [106]; Hammami 2018 [116]; He 2016 [167]; Henke 2016 [94]; Higashiyama 2012 [114]; Huijskens 2014,2015 [122,123]; Ichiyama 2015 [148]; Imtiyaz 2010 [87]; Ishii 2009 [139]; Jeong 2011,2014 [95,96]; Johnston 1991 [168]; Kasahara 2017 [158]; Kim 2012 [169]; Ko 2015 [170]; Kruidenier 2012 [141]; LaMere 2017 [151]; Labiano 2017 [119]; Li 2014 [153]; Li 2018 [83]; Lio 2016 [171]; Liu 2015 [154]; Maeng 2008 [172]; Manning 2013 [124]; Mecklenburgh 2002 [98]; Mingay 2018 [55]; Nair 2016 [156]; Nestor 2016 [147]; Nikolouli 2017 [157]; Noh 2005 [173]; Noman 2014 [92]; Northrup 2017 [161]; Oda 2006 [82]; Orlanski 2016 [174]; Palazon 2017 [117]; Perez-Cruz 2003 [103]; Peyssonnaux 2005 [85]; Ptaschinksi 2015 [146]; Puskas 2002 [175]; Satoh 2010 [134]; Shalova 2015 [89]; Shi 2011 [111]; Shilotri 1977 [176]; Song 2017 [159]; Talks 2000 [177]; Tsagaratou 2017 [160]; Vissers 2004,2007 [178,179]; Vojdani 1993 [180]; Wallner 2016 [132]; Walmsley 2005,2006 [99,100]; Wei 2009 [152]; Yan 2014 [140]; Yildirim 2017 [136]; Yue 2016 [155]; Zhang 2014,2015 [133,145].

Effects of HIFs and ascorbate on immune cells

Immune cells undergo dramatic metabolic changes following activation, and increased aerobic glycolytic activity and fatty acid oxidation have been observed [79,80]. These metabolic changes, once thought to be a consequence of cell activation, are now being re-examined as a mechanism for phenotype switching, termed metabolic reprogramming (reviewed in ref. [81]). Central to this switch are the HIF proteins which not only up-regulate the glycolytic machinery but also direct the inflammatory and immune response (reviewed in ref. [80]).

Monocytes/macrophages

The high ascorbate concentrations in monocytes [31] may be related to their dependency on HIF for many essential functions. HIF-1 has been shown to be activated in monocytes following activation with phorbol esters [82] and pathogenic stimuli [8386], even under non-hypoxic conditions. That HIF activation is an integral part of monocyte function is indicated by the demonstrations that HIF-1α or HIF-2α deletion in myeloid cells caused profound impairment of cell aggregation, motility, invasiveness and bacterial killing [8486], resulting in decreased bacterial resistance and failure to restrict systemic spread of a localised infection [8587]. HIF-1/2 appears to be important for monocyte-mediated host defence; HIF-1 activation has been shown to contribute to disease progression in colitis and myeloid HIF-1α knockout shifts the balance to an anti-inflammatory phenotype resulting in a less severe inflammation [88]. The sepsis-related host immunosuppressive monocyte phenotype has also been shown to be mediated by chronic HIF-1α expression, resulting in supressed pro-inflammatory cytokine expression and increased ability to induce Treg cell polarisation [89].

In cancer, activation of HIF-1/2 in monocytes has been implicated in the development and phenotype of tumour-associated macrophages [87,90]. This is associated with an increased M2-like gene profile, increased expression of immunosuppressive and pro-tumour proteins such as arginase 1, iNOS and VEGF, as well as induction of PD-L1 expression [87,9092]. These changes lead to greater monocyte/macrophage tumour invasion [87] and tumour cytotoxic T-cell suppression [92,93]. Interestingly, a macrophage-targeted HIF-1α and HIF-2α knockout resulted in delayed tumour progression in models of breast tumour, fibrosarcoma and colitis-associated colon carcinoma [87,93,94].

The potential complexity of ascorbate engagement with immune cells in the tumour microenvironment is well demonstrated by the observations that dendritic cells treated with ascorbate secreted increased levels of IL-12p70 after activation with LPS and induced more Th1 cytokine and IFN-γ, but less Th2-cytokine, IL-5 expression in naive T cells [95]. Ascorbate-treated dendritic cells also increased the frequency of IFN-γ + T cells when co-cultured with both CD4+ and CD8+ T cells and demonstrated an improved anti-tumour effect [96].

Neutrophils

Neutrophils are short-lived cells that are the first responders to an inflammatory challenge. Their recruitment to, and clearance from, inflammatory sites is dependent on the regulation of cell death and survival pathways [97]. It appears that HIF-1 and ascorbate are intimately involved in determining neutrophil cell fate. Hypoxia has been shown to prolong neutrophil survival via activation of HIF-1 and its downstream pathways [98100]. HIF-1 activation also enhanced overall neutrophil antibacterial function as demonstrated by increased susceptibility to bacterial keratitis in mice when HIF-1 was inhibited [101]. This was supported by findings of delayed rates of apoptosis and enhanced bacterial phagocytosis under normoxic conditions in neutrophils from patients with a monoallelic mutation of von Hippel Lindau protein who exhibit a ‘partial hypoxic’ phenotype [99]. These results suggest that a functional hypoxic response supports neutrophil function at hypoxic inflammatory sites in vivo. A similar anti-apoptotic phenotype in ascorbate-deficient neutrophils was shown to be associated with HIF-1 activation under normoxic conditions [102]. Recognition of aged neutrophils by macrophages was also reported and neutrophil clearance from an inflammatory site was delayed in deficient cells [102]. Interestingly, increasing neutrophil ascorbate content was found to inhibit neutrophil Fas-induced cell death [103] as well as the rates of neutrophil and monocyte apoptosis in patients with sepsis [104]. Also, in the ascorbate-dependent Gulo−/− mouse, a high ascorbate diet was found to increase circulating granulocyte and monocyte numbers [105].

Not all effects of ascorbate on neutrophil function will be HIF-related. Severe ascorbate deficiency has been shown to impair neutrophil bactericidal ability towards phagocytosed pathogens following infection with actimoycetes and K pneumoniae [106,107], possibly as a result of altered oxidative capacity. Neutrophils from individuals with suboptimal circulating ascorbate levels showed a modest increase in neutrophil chemotaxis and oxidative burst ex vivo following supplementation to restore vitamin C status to healthy levels [108]. Vitamin C deficiency also increased the generation of neutrophil extracellular traps (NETs) in the Gulo−/− mouse [109].

T cells

Differentiation of CD4 T cells dictates the type of inflammatory response occurring via the development of different T-helpers and iTreg subsets and their corresponding effector function [80,110]. Therefore, depending on the nature of the insult or source of inflammation, the prevailing ratio and species of T cells could alter the outcome. HIF-1 appears to play an important, although unresolved, role in T-cell differentiation. For example, HIF-1α T-cell-targeted knockout protected mice from autoimmune neuro-inflammation and was associated with a shift from TH17 to Treg response, possibly by increasing glycolysis [111113], while the opposite was observed in irritable bowel disease where T-cell HIF-1α knockout increased TH1 and TH17 leading to severe colonic inflammation [114]. HIF-1α-mediated myeloid- and dendritic cell-driven differentiation of T cells also greatly affected the inflammatory outcome; HIF-1α knockout in myeloid cells resulted in lesser TH17 prevalence and decreased inflammation [88]. In dendritic cells, HIF-1 knockout resulted in impaired Treg development and increased inflammation [115], and HIF-1-mediated events were reported to limit Th1 cell development by preventing IL-12 production and to exacerbate Leishmania infections [116].

Apart from T-cell differentiation, HIF-1 has also been shown to affect T-cell activation and function. HIF activation enhanced the expression of effector molecules, co-stimulatory receptors, activation and inhibitory receptors, and key transcriptional regulators of effector and memory cell differentiation [113,117]. However, this was in contrast with a previous report showing higher levels of pro-inflammatory cytokines, stronger antibacterial effects and much better survival of septic mice with T-cell targeted deletion of HIF-1α [118].

In cancer, HIF-1 activation is associated with expression of CD69 (a marker of activated T cells) on cytotoxic T lymphocytes (CTLs) in hypoxic regions of tumour, suggesting a pro-tumour killing role for HIF-1α [119]. This is supported by two studies, showing that T-cell HIF-1 activation significantly delayed tumour growth [113] and, conversely, accelerated tumour progression in the presence of HIF-1α knockout CTLs [117] in a murine model of ectopic B16 melanoma.

There have been many studies that have suggested that ascorbate influences lymphocyte differentiation, including early studies that indicated that increased circulating lymphocytes were associated with ascorbate availability [120,121]. High ascorbate supplementation for one-year also significantly increased all circulating leukocytes, including lymphocytes, in the SMP30KO ascorbate-dependent mice [105]. Ascorbate was required for the progression of mouse bone marrow-derived progenitor cells into functional T-lymphocytes and also increased the NK cell population in vitro [122124]. Many of these effects show a significant correlation with the regulation of the TET and Jumonji demethylases and epigenetic changes, rather than with the expression of HIF-1. This topic is discussed in the following section.

Ascorbate and the regulation of epigenetics in immune cells

In mammals, one of the most widespread epigenetic modifications is DNA cytosine methylation which can be actively reversed by the TET enzymes that catalyse the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [125]. Ascorbate availability enhances TET activity [126,127] through its cofactor function, likely maintaining the active site Fe2+ of these dioxygenases [128]. Although other reducing agents could reduce Fe3+ and promote TET activity in a cell free system, ascorbate was shown to be the most efficient [128] and glutathione was incapable of increasing murine embryonic TET activity compared with equimolar ascorbate [126,127]. The Jumonji C domain-containing histone demethylases (JHDMs) are also members of the Fe- and 2-oxoglutarate-dependent dioxygenase family and similarly to TETs, full enzyme activity of JHDMs occurs in the presence of ascorbate [129,130]. The JHDMs are the third and largest class of demethylase enzymes, capable of removing all three histone lysine-methylation states through oxidative reactions [130].

Monoytes/macrophages

Epigenetic regulation plays an important role in macrophage differentiation, with rapid TET-dependent demethylation observed in colony-stimulating factor-1-differentiated human monocytes [131,132]. TET2 transcription was further induced by LPS but not by IL-4 stimulation [131]. The genes affected by TET-mediated demethylation are part of ten consolidated pathways related to the regulation of actin cytoskeleton, phagocytosis and the innate immune system [132], and in macrophages, TET2 is thought to restrain the inflammatory response by up-regulating expression of genes involved in dampening Toll-like receptor 4 signalling [131]. This notion is supported by a report showing TET2 represses IL-6 production during LPS-induced inflammation and that TET2 knockout exacerbates the expression of macrophage pro-inflammatory molecules such as IL-6, MCP-1 and MCP-3 in response to LPS stimulation, resulting in an enhanced inflammatory response [133].

The JHDM enzyme JMJD3 is expressed in monocytes/macrophages and is inducible by differentiating factors [134136] as well as by pathogenic [137,138] and damage-associated molecules [139,140]. Although JMJD3 has been shown to affect gene expression in macrophages, the role of JMJD3 in macrophage function is still unclear. For example, 70% of macrophage–LPS–inducible genes were found to be JMJD3 targets but only a few hundred genes, including inducible inflammatory genes, were moderately affected by JMJD3 deletion [137]. However, Kruidenier et al. [141] demonstrated a drastic drop in LPS-induced cytokine expression using a specific JMJD3 inhibitor and siRNA, among them TNF-α. In contrast, Satoh et al. showed no effect on M1 cytokine secretion following LPS stimulation in JMJD3 knockout macrophages including TNF-α [134]. Contradictions aside, two studies looking at macrophage response to parasitic infection have associated JMJD3 demethylation activity with acquisition of an M2 phenotype, demonstrated by up-regulation of M2 proteins such as Arg1, Ym1, Fizz1, MR and iNOS [134,139]. Two other studies have associated JMJD3 activity with an M1 macrophage phenotype following serum amyloid A stimulation [140] and in arthritis [135] resulting in induction of pro-inflammatory cytokines.

Epigenetic processes regulated by the demethylases are associated with leukaemogenesis and ascorbate availability has been closely linked to this phenomenon. As mentioned above, haematopoietic stem and progenitor cells (HSPCs) accumulate high intracellular concentrations of ascorbate, and this is essential for HSPC differentiation via support of TET2 activity [53]. TET2 inhibition in HSPCs by ascorbate depletion retards differentiation and increases HPSC frequency. TET2 mutations are also known to co-operate with FLT3ITD mutations to cause acute myeloid leukaemia [53]. Ascorbate depletion coupled with FLT3ITD mutations was adequate for leukaemogenesis [53]. It appears then, that ascorbate accumulation within HSCs promotes TET function in vivo, limiting HSPC frequency and suppressing leukaemogenesis. These findings were corroborated in part by another group that described the use of ascorbate as a combination therapy for treating leukaemia [142]. Patients with leukaemia often have low plasma ascorbate levels [44,4750] and the capacity for ascorbate to influence the epigenetic drivers of some leukaemias has led to conjecture that increased ascorbate supply may provide clinical benefit to some individuals with leukaemia. Two recent publications have provided support for this hypothesis [143,144].

Dendritic cells

DNA demethylation changes occur during the development of monocytes into immature DCs and mature DCs [145]. TET2 represses late-phase expression of dendritic cell pro-inflammatory molecules such as IL-6, MCP-1 and MCP-3 in response to LPS stimulation and TET2 knockout results in a greater degree of inflammatory response in mice challenged with LPS and colitis [133]. KDM5B acts to repress type I IFN and other innate cytokines in DCs to promote an altered immune response following RSV infection that contributes to the development of chronic disease [146].

T cells

Widespread DNA methylation remodelling has been reported at genes and cell-specific enhancers with known T-cell function during human CD4+ T differentiation [147,148], and TET2 was reported to be the critical DNA demethylase involved in the differentiation of TH1 and TH17 cells, leading to activation of effector cytokine gene expression [148]. TET2 has also been shown to regulate CD8+ T-cell fate, particularly in formation of memory CD8+ T cells [149]. Prolonged antigen stimulation in peptide immunotherapy is associated with demethylation of conserved regions of PD-1 promoter, possibly via TET, leading to sustained PD-1 expression in CD4+ effector T cells [150].

Profound demethylation of histone H3K27 is observed after activation in CD4+ T cells and corresponds to pathways crucial to T-cell function, including T-cell activation and the regulation of the JAK/STAT pathways [151,152]. Deletion of the histone demethylase JMJD3 was found to regulate gene expression resulting in TH2 and TH17 differentiation and inhibiting TH1 and Treg cell differentiation via altered methylation status of H3K27 and/or H3K4 [153,154].

Recent studies focusing on the role of ascorbate in T-cell differentiation and function suggest close alignment with epigenetic regulation and demethylase activity. Initial work showed ascorbate to be required for the progression of mouse bone marrow-derived progenitor cells into functional T-lymphocytes in vitro and in vivo by a JMJC-mediated process [123,124]. Subsequent studies reported ascorbate-mediated stabilisation of Foxp3 expression in TGF-β-induced Tregs by TET enzymes [155,156]. Also, ascorbate enhanced alloantigen-induced Treg suppressive capacity in skin allograft and GVHD in mice was attributed to the stabilisation of Foxp3 expression, presumably via demethylation of Foxp3 and other Treg-specific epigenetic genes [157,158]. Apart from Tregs, ascorbate has also been implicated in the maintenance of TH17 phenotype by increasing IL-17 expression in TH17-differentiated T cells via reduced trimethylation of histone H3 lysine 9 (H3K9me3) in the regulatory elements of the IL-17 locus [159].

NK cells

Many recent studies have demonstrated the impact of TET- and JHDM-mediated demethylation on NKT cell development, proliferation and function [160162]. Interestingly, inhibition of the H3K27 demethylase reduced IFN-γ, TNF-α, GM-CSF and IL-10 levels in cytokine-stimulated NK cells while sparing their cytotoxic killing activity against cancer cells [163].

Summary

The demonstrated dependency of the Fe-containing 2-oxoglutarate-dependent dioxygenase family on ascorbate availability and the involvement of members of this family of enzymes on many immune cell functions provide a rational basis for the belief that ascorbate supports the immune system. Ascorbate availability will influence HIF activation and immune cell function in hypoxic inflammatory and tumour environments, affecting the resolution of inflammation and potentially tumour survival in as yet unknown ways. There is also an impressive amount of information emerging that highlights the impact of the TET DNA demethylases and some histone demethylases on epigenetic remodelling of immune cells. These enzymes have also been shown to be highly responsive to ascorbate, and new insights into ascorbate function in immunity will no doubt continue to emerge.

Abbreviations

     
  • CTLs

    cytotoxic T lymphocytes

  •  
  • HIFs

    hypoxia-inducible factors

  •  
  • HSPCs

    haematopoietic stem and progenitor cells

  •  
  • JHDMs

    Jumonji C domain-containing histone demethylases

  •  
  • NETs

    neutrophil extracellular traps

Competing Interests

The Authors declare that there are no competing interests associated with the manuscript.

References

References
1
Banhegyi
,
G.
,
Benedetti
,
A.
,
Margittai
,
E.
,
Marcolongo
,
P.
,
Fulceri
,
R.
,
Nemeth
,
C.E.
et al. 
(
2014
)
Subcellular compartmentation of ascorbate and its variation in disease states
.
Biochim. Biophys. Acta
1843
,
1909
1916
2
Sauberlich,
H.E.
(
1997
) A history of scurvy and vitamin C. In
Vitamin C in health and disease
,
1st edn.
(
Packer
,
L.
and
Fuchs
,
J.
, eds), pp.
1
24
,
Marcel Dekker, Inc.
,
New York
3
Frei
,
B.
,
Birlouez-Aragon
,
I.
and
Lykkesfeldt
,
J.
(
2012
)
Authors’ perspective: what is the optimum intake of vitamin C in humans?
Crit. Rev. Food Sci. Nutr.
52
,
815
829
4
Grosso
,
G.
,
Bei
,
R.
,
Mistretta
,
A.
,
Marventano
,
S.
,
Calabrese
,
G.
,
Masuelli
,
L.
et al. 
(
2013
)
Effects of vitamin C on health: a review of evidence
.
Front. Biosci.
18
,
1017
1029
5
Bergsten
,
P.
,
Amitai
,
G.
,
Kehrl
,
J.
,
Dhariwal
,
K.R.
,
Klein
,
H.G.
and
Levine
,
M.
(
1990
)
Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Depletion and reaccumulation
.
J. Biol. Chem.
265
,
2584
2587
PMID:
[PubMed]
6
Bergsten
,
P.
,
Yu
,
R.
,
Kehrl
,
J.
and
Levine
,
M.
(
1995
)
Ascorbic acid transport and distribution in human B lymphocytes
.
Arch. Biochem. Biophys.
317
,
208
214
7
Levine
,
M.
,
Dhariwal
,
K.R.
,
Welch
,
R.W.
,
Wang
,
Y.
and
Park
,
J.B.
(
1995
)
Determination of optimal vitamin C requirements in humans
.
Am. J. Clin. Nutr.
62
,
1347S
1356S
8
Levine
,
M.
,
Wang
,
Y.
,
Padayatty
,
S.J.
and
Morrow
,
J.
(
2001
)
A new recommended dietary allowance of vitamin C for healthy young women
.
Proc. Natl Acad. Sci. USA
98
,
9842
9846
9
Wang
,
Y.
,
Russo
,
T.A.
,
Kwon
,
O.
,
Chanock
,
S.
,
Rumsey
,
S.C.
and
Levine
,
M.
(
1997
)
Ascorbate recycling in human neutrophils: induction by bacteria
.
Proc. Natl Acad. Sci. USA
94
,
13816
13819
10
Peterkofsky
,
B.
(
1991
)
Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy
.
Am. J. Clin. Nutr.
54
,
1135S
1140S
11
Pihlajaniemi
,
T.
,
Myllylä
,
R.
and
Kivirikko
,
K.I.
(
1991
)
Prolyl 4-hydroxylase and its role in collagen synthesis
.
J. Hepatol.
13
,
S2
S7
12
Levine
,
M.
,
Morita
,
K.
,
Heldman
,
E.
and
Pollard
,
H.B.
(
1985
)
Ascorbic acid regulation of norepinephrine biosynthesis in isolated chromaffin granules from bovine adrenal medulla
.
J. Biol. Chem.
260
,
15598
15603
13
Englard
,
S.
and
Seifter
,
S.
(
1986
)
The biochemical functions of ascorbic acid
.
Annu. Rev. Nutr.
6
,
365
406
14
Kuiper
,
C.
and
Vissers
,
M.C.
(
2014
)
Ascorbate as a co-factor for Fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression
.
Front. Oncol.
4
,
359
15
Loenarz
,
C.
and
Schofield
,
C.J.
(
2011
)
Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases
.
Trends Biochem. Sci.
36
,
7
18
16
Nelson
,
P.J.
,
Pruitt
,
R.E.
,
Henderson
,
L.L.
,
Jenness
,
R.
and
Henderson
,
L.M.
(
1981
)
Effect of ascorbic acid deficiency on the in vivo synthesis of carnitine
.
Biochim. Biophys. Acta
672
,
123
127
17
Young
,
J.I.
,
Züchner
,
S.
and
Wang
,
G.
(
2015
)
Regulation of the epigenome by vitamin C
.
Annu. Rev. Nutr.
35
,
545
564
18
Camarena
,
V.
and
Wang
,
G.
(
2016
)
The epigenetic role of vitamin C in health and disease
.
Cell. Mol. Life Sci.
73
,
1645
1658
19
Stolze
,
I.P.
,
Mole
,
D.R.
and
Ratcliffe
,
P.J.
(
2006
)
Regulation of HIF: prolyl hydroxylases
.
Novartis Found Symp.
272
,
15
25
;
discussion 25–36
PMID:
[PubMed]
20
Vissers
,
M.C.
,
Kuiper
,
C.
and
Dachs
,
G.U.
(
2014
)
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
.
Biochem. Soc. Trans.
42
,
945
951
21
Bendich
,
A.
(
1990
)
Antioxidant vitamins and their functions in immune responses
.
Adv. Exp. Med. Biol.
262
,
35
55
22
Mangge
,
H.
,
Becker
,
K.
,
Fuchs
,
D.
and
Gostner
,
J.M.
(
2014
)
Antioxidants, inflammation and cardiovascular disease
.
World J. Cardiol.
6
,
462
477
23
Meydani
,
S.N.
,
Meydani
,
M.
and
Blumberg
,
J.B.
(
1990
)
Antioxidants and the aging immune response
.
Adv. Exp. Med. Biol.
262
,
57
67
24
Pohanka
,
M.
,
Pejchal
,
J.
,
Snopkova
,
S.
,
Havlickova
,
K.
,
Karasova
,
J.Z.
,
Bostik
,
P.
et al. 
(
2012
)
Ascorbic acid: an old player with a broad impact on body physiology including oxidative stress suppression and immunomodulation: a review
.
Mini-Rev. Med. Chem.
12
,
35
43
25
Puertollano
,
M.A.
,
Puertollano
,
E.
,
de Cienfuegos
,
G.A.
and
de Pablo
,
M.A.
(
2011
)
Dietary antioxidants: immunity and host defense
.
Curr. Top. Med. Chem.
11
,
1752
1766
26
Ginter
,
E.
,
Simko
,
V.
and
Panakova
,
V.
(
2014
)
Antioxidants in health and disease
.
Bratisl. Lek. Listy.
115
,
603
606
PMID:
[PubMed]
27
Maggini
,
S.
,
Wenzlaff
,
S.
and
Hornig
,
D.
(
2010
)
Essential role of vitamin C and zinc in child immunity and health
.
J. Int. Med. Res.
38
,
386
414
28
Flashman
,
E.
,
Davies
,
S.L.
,
Yeoh
,
K.K.
and
Schofield
,
C.J.
(
2010
)
Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents
.
Biochem. J.
427
,
135
142
29
Kuiper
,
C.
,
Dachs
,
G.U.
,
Currie
,
M.J.
and
Vissers
,
M.C.
(
2014
)
Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response
.
Free Radic. Biol. Med.
69
,
308
317
30
Banhegyi
,
G.
,
Braun
,
L.
,
Csala
,
M.
,
Puskas
,
F.
and
Mandl
,
J.
(
1997
)
Ascorbate metabolism and its regulation in animals
.
Free Radic. Biol. Med.
23
,
793
803
31
Levine
,
M.
,
Conry-Cantilena
,
C.
,
Wang
,
Y.
,
Welch
,
R.W.
,
Washko
,
P.W.
,
Dhariwal
,
K.R.
et al. 
(
1996
)
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance
.
Proc. Natl Acad. Sci. U.S.A.
93
,
3704
3709
32
Schleicher
,
R.L.
,
Carroll
,
M.D.
,
Ford
,
E.S.
and
Lacher
,
D.A.
(
2009
)
Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES)
.
Am. J. Clin. Nutr.
90
,
1252
1263
33
Carr
,
A.C.
,
Bozonet
,
S.M.
,
Pullar
,
J.M.
,
Simcock
,
J.W.
and
Vissers
,
M.C.
(
2013
)
Human skeletal muscle ascorbate is highly responsive to changes in vitamin C intake and plasma concentrations
.
Am. J. Clin. Nutr.
97
,
800
807
34
Carr
,
A.C.
,
Bozonet
,
S.M.
,
Pullar
,
J.M.
,
Simcock
,
J.W.
and
Vissers
,
M.C.
(
2013
)
A randomized steady-state bioavailability study of synthetic versus natural (kiwifruit-derived) vitamin C
.
Nutrients
5
,
3684
3695
35
Carr
,
A.C.
,
Bozonet
,
S.M.
,
Pullar
,
J.M.
and
Vissers
,
M.C.
(
2013
)
Mood improvement in young adult males following supplementation with gold kiwifruit, a high-vitamin C food
.
J. Nutr. Sci.
2
,
e24
36
Carr
,
A.C.
,
Bozonet
,
S.M.
and
Vissers
,
M.C.
(
2013
)
A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C
.
Nutrients
5
,
4451
4461
37
Bonham
,
M.J.
,
Abu-Zidan
,
F.M.
,
Simovic
,
M.O.
,
Sluis
,
K.B.
,
Wilkinson
,
A.
,
Winterbourn
,
C.C.
et al. 
(
1999
)
Early ascorbic acid depletion is related to the severity of acute pancreatitis
.
Br. J. Surg.
86
,
1296
1301
38
Jiang
,
Q.
,
Lykkesfeldt
,
J.
,
Shigenaga
,
M.K.
,
Shigeno
,
E.T.
,
Christen
,
S.
and
Ames
,
B.N.
(
2002
)
γ-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation
.
Free Radic. Biol. Med.
33
,
1534
1542
39
Bakaev
,
V.V.
and
Duntau
,
A.P.
(
2004
)
Ascorbic acid in blood serum of patients with pulmonary tuberculosis and pneumonia
.
Int. J. Tuber. Lung Dis.
8
,
263
266
PMID:
[PubMed]
40
Carr
,
A.C.
,
Rosengrave
,
P.C.
,
Bayer
,
S.
,
Chambers
,
S.
,
Mehrtens
,
J.
and
Shaw
,
G.M.
(
2017
)
Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes
.
Crit. Care
21
,
300
41
Basu
,
T.K.
,
Raven
,
R.W.
,
Dickerson
,
J.W.
and
Williams
,
D.C.
(
1974
)
Leucocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastases
.
Eur. J. Cancer
10
,
507
511
42
Anthony
,
H.M.
and
Schorah
,
C.J.
(
1982
)
Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance
.
Br. J. Cancer
46
,
354
367
43
Mayland
,
C.R.
,
Bennett
,
M.I.
and
Allan
,
K.
(
2005
)
Vitamin C deficiency in cancer patients
.
Palliat. Med.
19
,
17
20
44
Huijskens
,
M.J.
,
Wodzig
,
W.K.
,
Walczak
,
M.
,
Germeraad
,
W.T.
and
Bos
,
G.M.
(
2016
)
Ascorbic acid serum levels are reduced in patients with hematological malignancies
.
Results Immunol.
6
,
8
10
45
Abou-Seif
,
M.A.
,
Rabia
,
A.
and
Nasr
,
M.
(
2000
)
Antioxidant status, erythrocyte membrane lipid peroxidation and osmotic fragility in malignant lymphoma patients
.
Clin. Chem. Lab. Med.
38
,
737
742
46
Blair
,
C.K.
,
Roesler
,
M.
,
Xie
,
Y.
,
Gamis
,
A.S.
,
Olshan
,
A.F.
,
Heerema
,
N.A.
et al. 
(
2008
)
Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study
.
Paediatr. Perinat. Epidemiol.
22
,
288
295
47
Kennedy
,
D.D.
,
Tucker
,
K.L.
,
Ladas
,
E.D.
,
Rheingold
,
S.R.
,
Blumberg
,
J.
and
Kelly
,
K.M.
(
2004
)
Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia
.
Am. J. Clin. Nutr.
79
,
1029
1036
48
Nakagawa
,
K.
(
2000
)
Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia
.
Cell. Mol. Biol.
46
,
1375
1381
PMID:
[PubMed]
49
Neyestani
,
T.R.
,
Fereydouni
,
Z.
,
Hejazi
,
S.
,
Salehi-Nasab
,
F.
,
Nateghifard
,
F.
,
Maddah
,
M.
et al. 
(
2007
)
Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization
.
J. Pediatr. Gastroenterol. Nutr.
45
,
141
144
50
Sharma
,
A.
,
Tripathi
,
M.
,
Satyam
,
A.
and
Kumar
,
L.
(
2009
)
Study of antioxidant levels in patients with multiple myeloma
.
Leuk. Lymphoma
50
,
809
815
51
Evans-Olders
,
R.
,
Eintracht
,
S.
and
Hoffer
,
L.J.
(
2010
)
Metabolic origin of hypovitaminosis C in acutely hospitalized patients
.
Nutrition
26
,
1070
1074
52
Gan
,
R.
,
Eintracht
,
S.
and
Hoffer
,
L.J.
(
2008
)
Vitamin C deficiency in a university teaching hospital
.
J. Am. Coll. Nutr.
27
,
428
433
53
Agathocleous
,
M.
,
Meacham
,
C.E.
,
Burgess
,
R.J.
,
Piskounova
,
E.
,
Zhao
,
Z.
,
Crane
,
G.M.
et al. 
(
2017
)
Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
.
Nature
549
,
476
481
54
Mastrangelo
,
D.
,
Pelosi
,
E.
,
Castelli
,
G.
,
Lo-Coco
,
F.
and
Testa
,
U.
(
2018
)
Mechanisms of anti-cancer effects of ascorbate: cytotoxic activity and epigenetic modulation
.
Blood Cells Mol. Dis.
69
,
57
64
55
Mingay
,
M.
,
Chaturvedi
,
A.
,
Bilenky
,
M.
,
Cao
,
Q.
,
Jackson
,
L.
,
Hui
,
T.
et al. 
(
2018
)
Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia
.
Leukemia
32
,
11
20
56
Gillberg
,
L.
,
Orskov
,
A.D.
,
Liu
,
M.
,
Harslof
,
L.B.S.
,
Jones
,
P.A.
and
Gronbaek
,
K.
(
2018
)
Vitamin C—a new player in regulation of the cancer epigenome
.
Semin. Cancer Biol.
51
,
59
67
57
Vissers
,
M.C.M.
and
Das
,
A.B.
(
2018
)
Potential mechanisms of action for vitamin C in cancer: reviewing the evidence
.
Front. Physiol.
9
,
809
58
Kaelin
,
W.G.J.
and
Ratcliffe
,
P.J.
(
2008
)
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway
.
Mol. Cell
30
,
393
402
59
Ratcliffe
,
P.J.
(
2013
)
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
.
J. Physiol.
591
(
Pt 8
),
2027
2042
60
Semenza
,
G.L.
(
2010
)
HIF-1: upstream and downstream of cancer metabolism
.
Curr. Opin. Genet. Dev.
20
,
51
56
61
Ozer
,
A.
and
Bruick
,
R.K.
(
2007
)
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
Nat. Chem. Biol.
3
,
144
153
62
Jaakkola
,
P.
,
Mole
,
D.R.
,
Tian
,
Y.M.
,
Wilson
,
M.I.
,
Gielbert
,
J.
,
Gaskell
,
S.J.
et al. 
(
2001
)
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
.
Science
292
,
468
472
63
Hirsila
,
M.
,
Koivunen
,
P.
,
Gunzler
,
V.
,
Kivirikko
,
K.I.
and
Myllyharju
,
J.
(
2003
)
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
.
J. Biol. Chem.
278
,
30772
30780
64
Nytko
,
K.J.
,
Maeda
,
N.
,
Schlafli
,
P.
,
Spielmann
,
P.
,
Wenger
,
R.H.
and
Stiehl
,
D.P.
(
2011
)
Vitamin C is dispensable for oxygen sensing in vivo
.
Blood
117
,
5485
5493
65
Nytko
,
K.J.
,
Spielmann
,
P.
,
Camenisch
,
G.
,
Wenger
,
R.H.
and
Stiehl
,
D.P.
(
2007
)
Regulated function of the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins
.
Antioxid. Redox Signal.
9
,
1329
1338
66
Campbell
,
E.J.
,
Vissers
,
M.C.
and
Dachs
,
G.U.
(
2016
)
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo−/− mice
.
Hypoxia
4
,
41
52
67
Colgan
,
S.P.
,
Campbell
,
E.L.
and
Kominsky
,
D.J.
(
2016
)
Hypoxia and mucosal inflammation
.
Annu. Rev. Pathol.
11
,
77
100
68
Whyte
,
M.K.
and
Walmsley
,
S.R.
(
2014
)
The regulation of pulmonary inflammation by the hypoxia-inducible factor-hydroxylase oxygen-sensing pathway
.
Ann. Am. Thorac. Soc.
11
,
S271
S276
69
Campbell
,
E.L.
,
Bruyninckx
,
W.J.
,
Kelly
,
C.J.
,
Glover
,
L.E.
,
McNamee
,
E.N.
,
Bowers
,
B.E.
et al. 
(
2014
)
Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation
.
Immunity
40
,
66
77
70
Adam
,
J.
,
Yang
,
M.
,
Soga
,
T.
and
Pollard
,
P.J.
(
2014
)
Rare insights into cancer biology
.
Oncogene
33
,
2547
2556
71
Brahimi-Horn
,
M.C.
,
Chiche
,
J.
and
Pouysségur
,
J.
(
2007
)
Hypoxia and cancer
.
J. Mol. Med.
85
,
1301
1307
72
Potter
,
C.
and
Harris
,
A.L.
(
2004
)
Hypoxia inducible carbonic anhydrase IX, marker of tumour: hypoxia, survival pathway and therapy target
.
Cell Cycle
3
,
159
162
73
Semenza
,
G.L.
(
2015
)
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
.
Clin. Sci.
129
,
1037
1045
74
Karaczyn
,
A.
,
Ivanov
,
S.
,
Reynolds
,
M.
,
Zhitkovich
,
A.
,
Kasprzak
,
K.S.
and
Salnikow
,
K.
(
2006
)
Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel
.
J. Cell. Biochem.
97
,
1025
1035
75
Knowles
,
H.J.
,
Mole
,
D.R.
,
Ratcliffe
,
P.J.
and
Harris
,
A.L.
(
2006
)
Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1
.
Cancer Res.
66
,
2600
2607
76
Knowles
,
H.J.
,
Raval
,
R.R.
,
Harris
,
A.L.
and
Ratcliffe
,
P.J.
(
2003
)
Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells
.
Cancer Res.
63
,
1764
1768
PMID:
[PubMed]
77
Kuiper
,
C.
,
Dachs
,
G.U.
,
Munn
,
D.
,
Currie
,
M.J.
,
Robinson
,
B.A.
,
Pearson
,
J.F.
et al. 
(
2014
)
Increased tumor ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer
.
Front. Oncol.
4
,
10
78
Kuiper
,
C.
,
Molenaar
,
I.G.
,
Dachs
,
G.U.
,
Currie
,
M.J.
,
Sykes
,
P.H.
and
Vissers
,
M.C.
(
2010
)
Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer
.
Cancer Res.
70
,
5749
5758
79
Pearce
,
E.L.
and
Pearce
,
E.J.
(
2013
)
Metabolic pathways in immune cell activation and quiescence
.
Immunity
38
,
633
643
80
Corcoran
,
S.E.
and
O'Neill
,
L.A.
(
2016
)
HIF1α and metabolic reprogramming in inflammation
.
J. Clin. Invest.
126
,
3699
3707
81
Palsson-McDermott
,
E.M.
and
O'Neill
,
L.A.
(
2013
)
The Warburg effect then and now: from cancer to inflammatory diseases
.
BioEssays
35
,
965
973
82
Oda
,
T.
,
Hirota
,
K.
,
Nishi
,
K.
,
Takabuchi
,
S.
,
Oda
,
S.
,
Yamada
,
H.
et al. 
(
2006
)
Activation of hypoxia-inducible factor 1 during macrophage differentiation
.
Am. J. Physiol. Cell Physiol.
291
,
C104
C113
83
Li
,
C.
,
Wang
,
Y.
,
Li
,
Y.
,
Yu
,
Q.
,
Jin
,
X.
,
Wang
,
X.
et al. 
(
2018
)
HIF1α-dependent glycolysis promotes macrophage functional activities in protecting against bacterial and fungal infection
.
Sci. Rep.
8
,
3603
84
Cramer
,
T.
,
Yamanishi
,
Y.
,
Clausen
,
B.E.
,
Forster
,
I.
,
Pawlinski
,
R.
,
Mackman
,
N.
et al. 
(
2003
)
HIF-1α is essential for myeloid cell-mediated inflammation
.
Cell
112
,
645
657
85
Peyssonnaux
,
C.
,
Datta
,
V.
,
Cramer
,
T.
,
Doedens
,
A.
,
Theodorakis
,
E.A.
,
Gallo
,
R.L.
et al. 
(
2005
)
HIF-1α expression regulates the bactericidal capacity of phagocytes
.
J. Clin. Invest.
115
,
1806
1815
86
Braverman
,
J.
,
Sogi
,
K.M.
,
Benjamin
,
D.
,
Nomura
,
D.K.
and
Stanley
,
S.A.
(
2016
)
HIF-1α is an essential mediator of IFN-γ-dependent immunity to Mycobacterium tuberculosis
.
J. Immunol.
197
,
1287
1297
87
Imtiyaz
,
H.Z.
,
Williams
,
E.P.
,
Hickey
,
M.M.
,
Patel
,
S.A.
,
Durham
,
A.C.
,
Yuan
,
L.J.
et al. 
(
2010
)
Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation
.
J. Clin. Invest.
120
,
2699
2714
88
Backer
,
V.
,
Cheung
,
F.Y.
,
Siveke
,
J.T.
,
Fandrey
,
J.
and
Winning
,
S.
(
2017
)
Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis
.
PLoS ONE
12
,
e0190074
89
Shalova
,
I.N.
,
Lim
,
J.Y.
,
Chittezhath
,
M.
,
Zinkernagel
,
A.S.
,
Beasley
,
F.
,
Hernandez-Jimenez
,
E.
et al. 
(
2015
)
Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α
.
Immunity
42
,
484
498
90
Colegio
,
O.R.
,
Chu
,
N.Q.
,
Szabo
,
A.L.
,
Chu
,
T.
,
Rhebergen
,
A.M.
,
Jairam
,
V.
et al. 
(
2014
)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
.
Nature
513
,
559
563
91
Corzo
,
C.A.
,
Condamine
,
T.
,
Lu
,
L.
,
Cotter
,
M.J.
,
Youn
,
J.I.
,
Cheng
,
P.
et al. 
(
2010
)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
.
J. Exp. Med.
207
,
2439
2453
92
Noman
,
M.Z.
,
Desantis
,
G.
,
Janji
,
B.
,
Hasmim
,
M.
,
Karray
,
S.
,
Dessen
,
P.
et al. 
(
2014
)
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
.
J. Exp. Med.
211
,
781
790
93
Doedens
,
A.L.
,
Stockmann
,
C.
,
Rubinstein
,
M.P.
,
Liao
,
D.
,
Zhang
,
N.
,
DeNardo
,
D.G.
et al. 
(
2010
)
Macrophage expression of hypoxia-inducible factor-1α suppresses T-cell function and promotes tumor progression
.
Cancer Res.
70
,
7465
7475
94
Henke
,
N.
,
Ferreiros
,
N.
,
Geisslinger
,
G.
,
Ding
,
M.G.
,
Essler
,
S.
,
Fuhrmann
,
D.C.
et al. 
(
2016
)
Loss of HIF-1α in macrophages attenuates AhR/ARNT-mediated tumorigenesis in a PAH-driven tumor model
.
Oncotarget
7
,
25915
25929
95
Jeong
,
Y.J.
,
Hong
,
S.W.
,
Kim
,
J.H.
,
Jin
,
D.H.
,
Kang
,
J.S.
,
Lee
,
W.J.
et al. 
(
2011
)
Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naïve T cells into Th1 cells by increased IL-12 secretions
.
Cell. Immunol.
266
,
192
199
96
Jeong
,
Y.J.
,
Kim
,
J.H.
,
Hong
,
J.M.
,
Kang
,
J.S.
,
Kim
,
H.R.
,
Lee
,
W.J.
et al. 
(
2014
)
Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo
.
Immunobiology
219
,
554
564
97
Maianski
,
N.A.
,
Maianski
,
A.N.
,
Kuijpers
,
T.W.
and
Roos
,
D.
(
2004
)
Apoptosis of neutrophils
.
Acta Haematol.
111
,
56
66
98
Mecklenburgh
,
K.I.
,
Walmsley
,
S.R.
,
Cowburn
,
A.S.
,
Wiesener
,
M.
,
Reed
,
B.J.
,
Upton
,
P.D.
et al. 
(
2002
)
Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis
.
Blood
100
,
3008
3016
99
Walmsley
,
S.R.
,
Cowburn
,
A.S.
,
Clatworthy
,
M.R.
,
Morrell
,
N.W.
,
Roper
,
E.C.
,
Singleton
,
V.
et al. 
(
2006
)
Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis
.
Blood
108
,
3176
3178
100
Walmsley
,
S.R.
,
Print
,
C.
,
Farahi
,
N.
,
Peyssonnaux
,
C.
,
Johnson
,
R.S.
,
Cramer
,
T.
et al. 
(
2005
)
Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity
.
J. Exp. Med.
201
,
105
115
101
Berger
,
E.A.
,
McClellan
,
S.A.
,
Vistisen
,
K.S.
and
Hazlett
,
L.D.
(
2013
)
HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis
.
PLoS Pathog.
9
,
e1003457
102
Vissers
,
M.C.
,
Winterbourn
,
C.C.
and
Hunt
,
J.S.
(
1984
)
Degradation of glomerular basement membrane by human neutrophils in vitro
.
Biochim. Biophys. Acta
804
,
154
160
103
Perez-Cruz
,
I.
,
Carcamo
,
J.M.
and
Golde
,
D.W.
(
2003
)
Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells
.
Blood
102
,
336
343
104
Ferron-Celma
,
I.
,
Mansilla
,
A.
,
Hassan
,
L.
,
Garcia-Navarro
,
A.
,
Comino
,
A.M.
,
Bueno
,
P.
et al. 
(
2009
)
Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery
.
J. Surg. Res.
153
,
224
230
105
Uchio
,
R.
,
Hirose
,
Y.
,
Murosaki
,
S.
,
Yamamoto
,
Y.
and
Ishigami
,
A.
(
2015
)
High dietary intake of vitamin C suppresses age-related thymic atrophy and contributes to the maintenance of immune cells in vitamin C-deficient senescence marker protein-30 knockout mice
.
Br. J. Nutr.
113
,
603
609
106
Goldschmidt
,
M.C.
(
1991
)
Reduced bactericidal activity in neutrophils from scorbutic animals and the effect of ascorbic acid on these target bacteria in vivo and in vitro
.
Am. J. Clin. Nutr.
54
,
1214S
1220S
107
Gaut
,
J.P.
,
Belaaouaj
,
A.
,
Byun
,
J.
,
Roberts
, II,
L.J.
,
Maeda
,
N.
,
Frei
,
B.
et al. 
(
2006
)
Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation
.
Free Radic. Biol. Med.
40
,
1494
1501
108
Bozonet
,
S.M.
,
Carr
,
A.C.
,
Pullar
,
J.M.
and
Vissers
,
M.C.
(
2015
)
Enhanced human neutrophil vitamin C status, chemotaxis and oxidant generation following dietary supplementation with vitamin C-rich SunGold kiwifruit
.
Nutrients
7
,
2574
2588
109
Mohammed
,
B.M.
,
Fisher
,
B.J.
,
Kraskauskas
,
D.
,
Farkas
,
D.
,
Brophy
,
D.F.
,
Fowler
, III,
A.A.
et al. 
(
2013
)
Vitamin C: a novel regulator of neutrophil extracellular trap formation
.
Nutrients
5
,
3131
3151
110
Groux
,
H.
and
Powrie
,
F.
(
1999
)
Regulatory T cells and inflammatory bowel disease
.
Immunol. Today
20
,
442
445
111
Shi
,
L.Z.
,
Wang
,
R.
,
Huang
,
G.
,
Vogel
,
P.
,
Neale
,
G.
,
Green
,
D.R.
et al. 
(
2011
)
HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
.
J. Exp. Med.
208
,
1367
1376
112
Dang
,
E.V.
,
Barbi
,
J.
,
Yang
,
H.Y.
,
Jinasena
,
D.
,
Yu
,
H.
,
Zheng
,
Y.
et al. 
(
2011
)
Control of TH17/Treg balance by hypoxia-inducible factor 1
.
Cell
146
,
772
784
113
Doedens
,
A.L.
,
Phan
,
A.T.
,
Stradner
,
M.H.
,
Fujimoto
,
J.K.
,
Nguyen
,
J.V.
,
Yang
,
E.
et al. 
(
2013
)
Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
.
Nat. Immunol.
14
,
1173
1182
114
Higashiyama
,
M.
,
Hokari
,
R.
,
Hozumi
,
H.
,
Kurihara
,
C.
,
Ueda
,
T.
,
Watanabe
,
C.
et al. 
(
2012
)
HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis
.
J. Leukoc. Biol.
91
,
901
909
115
Flück
,
K.
,
Breves
,
G.
,
Fandrey
,
J.
and
Winning
,
S.
(
2016
)
Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis
.
Mucosal Immunol.
9
,
379
390
116
Hammami
,
A.
,
Abidin
,
B.M.
,
Heinonen
,
K.M.
and
Stäger
,
S.
(
2018
)
HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
.
Sci. Rep.
8
,
3500
117
Palazon
,
A.
,
Tyrakis
,
P.A.
,
Macias
,
D.
,
Velica
,
P.
,
Rundqvist
,
H.
,
Fitzpatrick
,
S.
et al. 
(
2017
)
An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression
.
Cancer Cell
32
,
669
683.e5
118
Thiel
,
M.
,
Caldwell
,
C.C.
,
Kreth
,
S.
,
Kuboki
,
S.
,
Chen
,
P.
,
Smith
,
P.
et al. 
(
2007
)
Targeted deletion of HIF-1α gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival
.
PLoS ONE
2
,
e853
119
Labiano
,
S.
,
Melendez-Rodriguez
,
F.
,
Palazon
,
A.
,
Teijeira
,
A.
,
Garasa
,
S.
,
Etxeberria
,
I.
et al. 
(
2017
)
CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes
.
Oncoimmunology
6
,
e1283468
120
Fraser
,
R.C.
,
Pavlovic
,
S.
,
Kurahara
,
C.G.
,
Murata
,
A.
,
Peterson
,
N.S.
,
Taylor
,
K.B.
et al. 
(
1980
)
The effect of variations in vitamin C intake on the cellular immune response of guinea pigs
.
Am. J. Clin. Nutr.
33
,
839
847
121
Kennes
,
B.
,
Dumont
,
I.
,
Brohee
,
D.
,
Hubert
,
C.
and
Neve
,
P.
(
1983
)
Effect of vitamin C supplements on cell-mediated immunity in old people
.
Gerontology
29
,
305
310
122
Huijskens
,
M.J.
,
Walczak
,
M.
,
Koller
,
N.
,
Briede
,
J.J.
,
Senden-Gijsbers
,
B.L.
,
Schnijderberg
,
M.C.
et al. 
(
2014
)
Technical advance: ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells
.
J. Leukoc. Biol.
96
,
1165
1175
123
Huijskens
,
M.J.
,
Walczak
,
M.
,
Sarkar
,
S.
,
Atrafi
,
F.
,
Senden-Gijsbers
,
B.L.
,
Tilanus
,
M.G.
et al. 
(
2015
)
Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy
.
Cytotherapy
17
,
613
620
124
Manning
,
J.
,
Mitchell
,
B.
,
Appadurai
,
D.A.
,
Shakya
,
A.
,
Pierce
,
L.J.
,
Wang
,
H.
et al. 
(
2013
)
Vitamin C promotes maturation of T-cells
.
Antioxid. Redox Signal.
19
,
2054
2067
125
Wu
,
X.
and
Zhang
,
Y.
(
2017
)
TET-mediated active DNA demethylation: mechanism, function and beyond
.
Nat. Rev. Genet.
18
,
517
534
126
Blaschke
,
K.
,
Ebata
,
K.T.
,
Karimi
,
M.M.
,
Zepeda-Martinez
,
J.A.
,
Goyal
,
P.
,
Mahapatra
,
S.
et al. 
(
2013
)
Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
.
Nature
500
,
222
226
127
Minor
,
E.A.
,
Court
,
B.L.
,
Young
,
J.I.
and
Wang
,
G.
(
2013
)
Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine
.
J. Biol. Chem.
288
,
13669
13674
128
Hore
,
T.A.
(
2017
)
Modulating epigenetic memory through vitamins and TET: implications for regenerative medicine and cancer treatment
.
Epigenomics
9
,
863
871
129
Tsukada
,
Y.
,
Fang
,
J.
,
Erdjument-Bromage
,
H.
,
Warren
,
M.E.
,
Borchers
,
C.H.
,
Tempst
,
P.
et al. 
(
2006
)
Histone demethylation by a family of JmjC domain-containing proteins
.
Nature
439
,
811
816
130
Klose
,
R.J.
,
Kallin
,
E.M.
and
Zhang
,
Y.
(
2006
)
JmjC-domain-containing proteins and histone demethylation
.
Nat. Rev. Genet.
7
,
715
727
131
Cull
,
A.H.
,
Snetsinger
,
B.
,
Buckstein
,
R.
,
Wells
,
R.A.
and
Rauh
,
M.J.
(
2017
)
Tet2 restrains inflammatory gene expression in macrophages
.
Exp. Hematol.
55
,
56
70.e13
132
Wallner
,
S.
,
Schroder
,
C.
,
Leitao
,
E.
,
Berulava
,
T.
,
Haak
,
C.
,
Beisser
,
D.
et al. 
(
2016
)
Epigenetic dynamics of monocyte-to-macrophage differentiation
.
Epigenetics Chromatin
9
,
74
133
Zhang
,
Q.
,
Zhao
,
K.
,
Shen
,
Q.
,
Han
,
Y.
,
Gu
,
Y.
,
Li
,
X.
et al. 
(
2015
)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
.
Nature
525
,
389
393
134
Satoh
,
T.
,
Takeuchi
,
O.
,
Vandenbon
,
A.
,
Yasuda
,
K.
,
Tanaka
,
Y.
,
Kumagai
,
Y.
et al. 
(
2010
)
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection
.
Nat. Immunol.
11
,
936
944
135
Achuthan
,
A.
,
Cook
,
A.D.
,
Lee
,
M.C.
,
Saleh
,
R.
,
Khiew
,
H.W.
,
Chang
,
M.W.
et al. 
(
2016
)
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation
.
J. Clin. Invest.
126
,
3453
3466
136
Yıldırım-Buharalıoğlu
,
G.
,
Bond
,
M.
,
Sala-Newby
,
G.B.
,
Hindmarch
,
C.C.
and
Newby
,
A.C.
(
2017
)
Regulation of epigenetic modifiers, including KDM6B, by interferon-γ and interleukin-4 in human macrophages
.
Front. Immunol.
8
,
92
137
De Santa
,
F.
,
Narang
,
V.
,
Yap
,
Z.H.
,
Tusi
,
B.K.
,
Burgold
,
T.
,
Austenaa
,
L.
et al. 
(
2009
)
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
.
EMBO J.
28
,
3341
3352
138
De Santa
,
F.
,
Totaro
,
M.G.
,
Prosperini
,
E.
,
Notarbartolo
,
S.
,
Testa
,
G.
and
Natoli
,
G.
(
2007
)
The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing
.
Cell
130
,
1083
1094
139
Ishii
,
M.
,
Wen
,
H.
,
Corsa
,
C.A.
,
Liu
,
T.
,
Coelho
,
A.L.
,
Allen
,
R.M.
et al. 
(
2009
)
Epigenetic regulation of the alternatively activated macrophage phenotype
.
Blood
114
,
3244
3254
140
Yan
,
Q.
,
Sun
,
L.
,
Zhu
,
Z.
,
Wang
,
L.
,
Li
,
S.
and
Ye
,
R.D.
(
2014
)
Jmjd3-mediated epigenetic regulation of inflammatory cytokine gene expression in serum amyloid A-stimulated macrophages
.
Cell. Signal.
26
,
1783
1791
141
Kruidenier
,
L.
,
Chung
,
C.W.
,
Cheng
,
Z.
,
Liddle
,
J.
,
Che
,
K.
,
Joberty
,
G.
et al. 
(
2012
)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
.
Nature
488
,
404
408
142
Cimmino
,
L.
,
Dolgalev
,
I.
,
Wang
,
Y.
,
Yoshimi
,
A.
,
Martin
,
G.H.
,
Wang
,
J.
et al. 
(
2017
)
Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
.
Cell
170
,
1079
1095.e20
143
Foster
,
M.N.
,
Carr
,
A.C.
,
Antony
,
A.
,
Peng
,
S.
and
Fitzpatrick
,
M.G.
(
2018
)
Intravenous vitamin C administration improved blood cell counts and health-related quality of life of patient with history of relapsed acute myeloid leukaemia
.
Antioxidants
7
,
E92
144
Zhao
,
H.
,
Zhu
,
H.
,
Huang
,
J.
,
Zhu
,
Y.
,
Hong
,
M.
,
Zhu
,
H.
et al. 
(
2018
)
The synergy of vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
.
Leuk. Res.
66
,
1
7
145
Zhang
,
X.
,
Ulm
,
A.
,
Somineni
,
H.K.
,
Oh
,
S.
,
Weirauch
,
M.T.
,
Zhang
,
H.X.
et al. 
(
2014
)
DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells
.
Epigenetics Chromatin
7
,
21
146
Ptaschinski
,
C.
,
Mukherjee
,
S.
,
Moore
,
M.L.
,
Albert
,
M.
,
Helin
,
K.
,
Kunkel
,
S.L.
et al. 
(
2015
)
RSV-induced H3K4 demethylase KDM5B leads to regulation of dendritic cell-derived innate cytokines and exacerbates pathogenesis in vivo
.
PLoS Pathog.
11
,
e1004978
147
Nestor
,
C.E.
,
Lentini
,
A.
,
Hagg Nilsson
,
C.
,
Gawel
,
D.R.
,
Gustafsson
,
M.
,
Mattson
,
L.
et al. 
(
2016
)
5-Hydroxymethylcytosine remodeling precedes lineage specification during differentiation of human CD4+ T cells
.
Cell Rep.
16
,
559
570
148
Ichiyama
,
K.
,
Chen
,
T.
,
Wang
,
X.
,
Yan
,
X.
,
Kim
,
B.S.
,
Tanaka
,
S.
et al. 
(
2015
)
The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells
.
Immunity
42
,
613
626
149
Carty
,
S.A.
,
Gohil
,
M.
,
Banks
,
L.B.
,
Cotton
,
R.M.
,
Johnson
,
M.E.
,
Stelekati
,
E.
et al. 
(
2018
)
The loss of TET2 promotes CD8+ T cell memory differentiation
.
J. Immunol.
200
,
82
91
150
McPherson
,
R.C.
,
Konkel
,
J.E.
,
Prendergast
,
C.T.
,
Thomson
,
J.P.
,
Ottaviano
,
R.
,
Leech
,
M.D.
et al. 
(
2014
)
Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy
.
eLife
3
,
e03416
151
LaMere
,
S.A.
,
Thompson
,
R.C.
,
Meng
,
X.
,
Komori
,
H.K.
,
Mark
,
A.
and
Salomon
,
D.R.
(
2017
)
H3k27 methylation dynamics during CD4 T cell activation: regulation of JAK/STAT and IL12RB2 expression by JMJD3
.
J. Immunol.
199
,
3158
3175
152
Wei
,
G.
,
Wei
,
L.
,
Zhu
,
J.
,
Zang
,
C.
,
Hu-Li
,
J.
,
Yao
,
Z.
et al. 
(
2009
)
Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells
.
Immunity
30
,
155
167
153
Li
,
Q.
,
Zou
,
J.
,
Wang
,
M.
,
Ding
,
X.
,
Chepelev
,
I.
,
Zhou
,
X.
et al. 
(
2014
)
Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation
.
Nat. Commun.
5
,
5780
154
Liu
,
Z.
,
Cao
,
W.
,
Xu
,
L.
,
Chen
,
X.
,
Zhan
,
Y.
,
Yang
,
Q.
et al. 
(
2015
)
The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation
.
J. Mol. Cell Biol.
7
,
505
516
155
Yue
,
X.
,
Trifari
,
S.
,
Aijo
,
T.
,
Tsagaratou
,
A.
,
Pastor
,
W.A.
,
Zepeda-Martinez
,
J.A.
et al. 
(
2016
)
Control of Foxp3 stability through modulation of TET activity
.
J. Exp. Med.
213
,
377
397
156
Sasidharan Nair
,
V.
,
Song
,
M.H.
and
Oh
,
K.I.
(
2016
)
Vitamin C facilitates demethylation of the Foxp3 enhancer in a Tet-dependent manner
.
J. Immunol.
196
,
2119
2131
157
Nikolouli
,
E.
,
Hardtke-Wolenski
,
M.
,
Hapke
,
M.
,
Beckstette
,
M.
,
Geffers
,
R.
,
Floess
,
S.
et al. 
(
2017
)
Alloantigen-induced regulatory T cells generated in presence of vitamin C display enhanced stability of Foxp3 expression and promote skin allograft acceptance
.
Front. Immunol.
8
,
748
158
Kasahara
,
H.
,
Kondo
,
T.
,
Nakatsukasa
,
H.
,
Chikuma
,
S.
,
Ito
,
M.
,
Ando
,
M.
et al. 
(
2017
)
Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model
.
Int. Immunol.
29
,
457
469
159
Song
,
M.H.
,
Nair
,
V.S.
and
Oh
,
K.I.
(
2017
)
Vitamin C enhances the expression of IL17 in a Jmjd2-dependent manner
.
BMB Rep.
50
,
49
54
160
Tsagaratou
,
A.
,
Gonzalez-Avalos
,
E.
,
Rautio
,
S.
,
Scott-Browne
,
J.P.
,
Togher
,
S.
,
Pastor
,
W.A.
et al. 
(
2017
)
TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells
.
Nat. Immunol.
18
,
45
53
161
Northrup
,
D.
,
Yagi
,
R.
,
Cui
,
K.
,
Proctor
,
W.R.
,
Wang
,
C.
,
Placek
,
K.
et al. 
(
2017
)
Histone demethylases UTX and JMJD3 are required for NKT cell development in mice
.
Cell Biosci.
7
,
25
162
Beyaz
,
S.
,
Kim
,
J.H.
,
Pinello
,
L.
,
Xifaras
,
M.E.
,
Hu
,
Y.
,
Huang
,
J.
et al. 
(
2017
)
The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells
.
Nat. Immunol.
18
,
184
195
163
Cribbs
,
A.
,
Hookway
,
E.S.
,
Wells
,
G.
,
Lindow
,
M.
,
Obad
,
S.
,
Oerum
,
H.
et al. 
(
2018
)
Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells
.
J. Biol. Chem.
293
,
2422
2437
164
Anderson
,
R.
,
Oosthuizen
,
R.
,
Maritz
,
R.
,
Theron
,
A.
and
Van Rensburg
,
A.J.
(
1980
)
The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers
.
Am. J. Clin. Nutr.
33
,
71
76
PMID:
[PubMed]
165
Bhandari
,
T.
,
Olson
,
J.
,
Johnson
,
R.S.
and
Nizet
,
V.
(
2013
)
HIF-1alpha influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination
.
J. Mol. Med.
91
,
1199
1205
166
Campbell
,
J.D.
,
Cole
,
M.
,
Bunditrutavorn
,
B.
and
Vella
,
A.T.
(
1999
)
Ascorbic acid is a potent inhibitor of various forms of T cell apoptosis
.
Cell. Immunol.
194
,
1
5
PMID:
[PubMed]
167
He
,
C.
,
Larson-Casey
,
J.L.
,
Gu
,
L.
,
Ryan
,
A.J.
,
Murthy
,
S.
and
Carter
,
A.B.
(
2016
)
Cu,Zn-superoxide dismutase-mediated redox regulation of Jumonji domain containing 3 modulates macrophage polarization and pulmonary fibrosis
.
Am. J. Respir. Cell Mol. Biol.
55
,
58
71
168
Johnston
,
C.S.
and
Huang
,
S.N.
(
1991
)
Effect of ascorbic acid nutriture on blood histamine and neutrophil chemotaxis in guinea pigs
.
J. Nutr.
121
,
126
130
PMID:
[PubMed]
169
Kim
,
J.E.
,
Cho
,
H.S.
,
Yang
,
H.S.
,
Jung
,
D.J.
,
Hong
,
S.W.
,
Hung
,
C.F.
et al. 
(
2012
)
Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model
.
Immunobiology
217
,
873
881
170
Ko
,
M.
,
An
,
J.
,
Pastor
,
W.A.
,
Koralov
,
S.B.
,
Rajewsky
,
K.
and
Rao
,
A.
(
2015
)
TET proteins and 5-methylcytosine oxidation in hematological cancers
.
Immunol. Rev
.
263
,
6
21
171
Lio
,
C.W.
,
Zhang
,
J.
,
Gonzalez-Avalos
,
E.
,
Hogan
,
P.G.
,
Chang
,
X.
and
Rao
,
A.
(
2016
)
Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility
.
eLife
5
172
Maeng
,
H.G.
,
Lim
,
H.
,
Jeong
,
Y.J.
,
Woo
,
A.
,
Kang
,
J.S.
,
Lee
,
W.J.
et al. 
(
2009
)
Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects
.
Immunobiology
214
,
311
320
173
Noh
,
K.
,
Lim
,
H.
,
Moon
,
S.K.
,
Kang
,
J.S.
,
Lee
,
W.J.
,
Lee
,
D.
et al. 
(
2005
)
Mega-dose Vitamin C modulates T cell functions in Balb/c mice only when administered during T cell activation
.
Immunol. Lett
.
98
,
63
72
PMID:
[PubMed]
174
Orlanski
,
S.
,
Labi
,
V.
,
Reizel
,
Y.
,
Spiro
,
A.
,
Lichtenstein
,
M.
,
Levin-Klein
,
R.
et al. 
(
2016
)
Tissue-specific DNA demethylation is required for proper B-cell differentiation and function
.
Proc. Natl. Acad. Sci. U.S.A.
113
,
5018
5023
175
Puskas
,
F.
,
Gergely
,
P.
,
Niland
,
B.
,
Banki
,
K.
and
Perl
,
A.
(
2002
)
Differential regulation of hydrogen peroxide and Fas-dependent apoptosis pathways by dehydroascorbate, the oxidized form of vitamin C
.
Antioxid. Redox Signal.
4
,
357
369
PMID:
[PubMed]
176
Shilotri
,
P.G.
(
1977
)
Phagocytosis and leukocyte enzymes in ascorbic acid deficient guinea pigs
.
J. Nutr.
107
,
1513
1516
PMID:
[PubMed]
177
Talks
,
K.L.
,
Turley
,
H.
,
Gatter
,
K.C.
,
Maxwell
,
P.H.
,
Pugh
,
C.W.
,
Ratcliffe
,
P.J.
et al. 
(
2000
)
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages
.
Am. J. Pathol.
157
,
411
421
PMID:
[PubMed]
178
Vissers
,
M.C.
and
Hampton
,
M.B.
(
2004
)
The role of oxidants and vitamin C on neutrophil apoptosis and clearance
.
Biochem. Soc. Trans.
32
,
499
501
179
Vissers
,
M.C.
and
Wilkie
,
R.P.
(
2007
)
Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha
.
J. Leukoc. Biol.
81
,
1236
1244
180
Vojdani
,
A.
and
Ghoneum
,
M.
(
1993
)
In vivo effect of ascorbic acid on enhancement of human natural killer cell activity
.
Nutr. Res.
13
,
753
764
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).